Literature DB >> 26162350

A killer combination that must be stopped.

Ramnath Subbaraman1, Madhukar Pai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26162350      PMCID： PMC4503371          DOI： 10.5588/ijtld.15.0458

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  9 in total

1.  Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew Gray; Tanuja Gengiah; Gonasagrie Nair; Sheila Bamber; Aarthi Singh; Munira Khan; Jacqueline Pienaar; Wafaa El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 2.  Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis.

Authors:  P Isaakidis; E C Casas; M Das; X Tseretopoulou; E E Ntzani; N Ford
Journal:  Int J Tuberc Lung Dis       Date:  2015-08       Impact factor: 2.373

3.  Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.

Authors:  Mark J Siedner; Courtney K Ng; Ingrid V Bassett; Ingrid T Katz; David R Bangsberg; Alexander C Tsai
Journal:  Clin Infect Dis       Date:  2014-12-16       Impact factor: 9.079

Review 4.  Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  Evan W Orenstein; Sanjay Basu; N Sarita Shah; Jason R Andrews; Gerald H Friedland; Anthony P Moll; Neel R Gandhi; Alison P Galvani
Journal:  Lancet Infect Dis       Date:  2009-03       Impact factor: 25.071

5.  WHO's new end TB strategy.

Authors:  Mukund Uplekar; Diana Weil; Knut Lonnroth; Ernesto Jaramillo; Christian Lienhardt; Hannah Monica Dias; Dennis Falzon; Katherine Floyd; Giuliano Gargioni; Haileyesus Getahun; Christopher Gilpin; Philippe Glaziou; Malgorzata Grzemska; Fuad Mirzayev; Hiroki Nakatani; Mario Raviglione
Journal:  Lancet       Date:  2015-03-24       Impact factor: 79.321

Review 6.  Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.

Authors:  Matthew Arentz; Patricia Pavlinac; Michael E Kimerling; David J Horne; Dennis Falzon; Holger J Schünemann; Sarah Royce; Keertan Dheda; Judd L Walson
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

Review 7.  Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  James C Johnston; Neal C Shahidi; Mohsen Sadatsafavi; J Mark Fitzgerald
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

8.  Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Authors:  Shama D Ahuja; David Ashkin; Monika Avendano; Rita Banerjee; Melissa Bauer; Jamie N Bayona; Mercedes C Becerra; Andrea Benedetti; Marcos Burgos; Rosella Centis; Eward D Chan; Chen-Yuan Chiang; Helen Cox; Lia D'Ambrosio; Kathy DeRiemer; Nguyen Huy Dung; Donald Enarson; Dennis Falzon; Katherine Flanagan; Jennifer Flood; Maria L Garcia-Garcia; Neel Gandhi; Reuben M Granich; Maria G Hollm-Delgado; Timothy H Holtz; Michael D Iseman; Leah G Jarlsberg; Salmaan Keshavjee; Hye-Ryoun Kim; Won-Jung Koh; Joey Lancaster; Christophe Lange; Wiel C M de Lange; Vaira Leimane; Chi Chiu Leung; Jiehui Li; Dick Menzies; Giovanni B Migliori; Sergey P Mishustin; Carole D Mitnick; Masa Narita; Philly O'Riordan; Madhukar Pai; Domingo Palmero; Seung-kyu Park; Geoffrey Pasvol; Jose Peña; Carlos Pérez-Guzmán; Maria I D Quelapio; Alfredo Ponce-de-Leon; Vija Riekstina; Jerome Robert; Sarah Royce; H Simon Schaaf; Kwonjune J Seung; Lena Shah; Tae Sun Shim; Sonya S Shin; Yuji Shiraishi; José Sifuentes-Osornio; Giovanni Sotgiu; Matthew J Strand; Payam Tabarsi; Thelma E Tupasi; Robert van Altena; Martie Van der Walt; Tjip S Van der Werf; Mario H Vargas; Pirett Viiklepp; Janice Westenhouse; Wing Wai Yew; Jae-Joon Yim
Journal:  PLoS Med       Date:  2012-08-28       Impact factor: 11.069

9.  Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.

Authors:  Lukas Fenner; Marie Ballif; Claire Graber; Venerandah Nhandu; Jean Claude Dusingize; Claudia P Cortes; Gabriela Carriquiry; Kathryn Anastos; Daniela Garone; Eefje Jong; Joachim Charles Gnokoro; Omar Sued; Samuel Ajayi; Lameck Diero; Kara Wools-Kaloustian; Sasisopin Kiertiburanakul; Barbara Castelnuovo; Charlotte Lewden; Nicolas Durier; Timothy R Sterling; Matthias Egger
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.